感染性心内膜炎外科治疗中国专家共识

2022-03-30 中华胸心血管外科杂志

本共识由中华医学会胸心血管外科分会编写,瓣膜病外科学组负责实施,综合心血管外科学、心脏病学和感染病学领域感染性心内膜炎(IE)治疗相关内容,分析国内、外相关研究成果,结合国内现状与专家组经验,评估各种

中文标题:

感染性心内膜炎外科治疗中国专家共识

发布机构:

发布日期:

2022-03-30

简要介绍:

本共识由中华医学会胸心血管外科分会编写,瓣膜病外科学组负责实施,综合心血管外科学、心脏病学和感染病学领域感染性心内膜炎(IE)治疗相关内容,分析国内、外相关研究成果,结合国内现状与专家组经验,评估各种诊疗方法的证据与推荐等级,重点阐明IE围手术期所面临的关键问题,为我国心血管外科医师提供策略及建议,提升我国IE外科精益化诊疗水平。

相关资料下载:
[AttachmentFileName(sort=1, fileName=感染性心内膜炎外科治疗中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c74621c002a43eee, title=感染性心内膜炎外科治疗中国专家共识, enTitle=, guiderFrom=中华胸心血管外科杂志, authorId=0, author=, summary=本共识由中华医学会胸心血管外科分会编写,瓣膜病外科学组负责实施,综合心血管外科学、心脏病学和感染病学领域感染性心内膜炎(IE)治疗相关内容,分析国内、外相关研究成果,结合国内现状与专家组经验,评估各种, cover=https://img.medsci.cn/20220519/1652950469391_5579292.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Mar 30 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">本共识由中华医学会胸心血管外科分会编写,瓣膜病外科学组负责实施,综合心血管外科学、心脏病学和感染病学领域感染性心内膜炎(IE)治疗相关内容,分析国内、外相关研究成果,结合国内现状与专家组经验,评估各种诊疗方法的证据与推荐等级,重点阐明IE围手术期所面临的关键问题,为我国心血管外科医师提供策略及建议,提升我国IE外科精益化诊疗水平。</span></p>, tagList=[TagDto(tagId=2738, tagName=外科治疗), TagDto(tagId=4248, tagName=感染性心内膜炎), TagDto(tagId=12269, tagName=心脏外科)], categoryList=[CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13991, appHits=140, showAppHits=0, pcHits=862, showPcHits=13849, likes=1, shares=33, comments=4, approvalStatus=1, publishedTime=Fri May 20 15:29:00 CST 2022, publishedTimeString=2022-03-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Thu May 19 16:58:08 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 13:37:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=感染性心内膜炎外科治疗中国专家共识.pdf)])
感染性心内膜炎外科治疗中国专家共识.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1235931, encodeId=fd621235931be, content=指南深入浅出,指导临床工作, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee495568458, createdName=123亮, createdTime=Mon Aug 01 13:27:32 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233320, encodeId=e0a012333201f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=164c1456793, createdName=zhlgzb, createdTime=Mon Jul 18 23:54:31 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229723, encodeId=8d351229e2327, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Jun 30 14:20:44 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221330, encodeId=a7be122133058, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Sat May 21 07:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=)]
    2022-08-01 123亮

    指南深入浅出,指导临床工作

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1235931, encodeId=fd621235931be, content=指南深入浅出,指导临床工作, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee495568458, createdName=123亮, createdTime=Mon Aug 01 13:27:32 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233320, encodeId=e0a012333201f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=164c1456793, createdName=zhlgzb, createdTime=Mon Jul 18 23:54:31 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229723, encodeId=8d351229e2327, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Jun 30 14:20:44 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221330, encodeId=a7be122133058, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Sat May 21 07:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=)]
    2022-07-18 zhlgzb

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1235931, encodeId=fd621235931be, content=指南深入浅出,指导临床工作, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee495568458, createdName=123亮, createdTime=Mon Aug 01 13:27:32 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233320, encodeId=e0a012333201f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=164c1456793, createdName=zhlgzb, createdTime=Mon Jul 18 23:54:31 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229723, encodeId=8d351229e2327, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Jun 30 14:20:44 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221330, encodeId=a7be122133058, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Sat May 21 07:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=)]
    2022-06-30 1de5ae28m43(暂无匿称)

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1235931, encodeId=fd621235931be, content=指南深入浅出,指导临床工作, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee495568458, createdName=123亮, createdTime=Mon Aug 01 13:27:32 CST 2022, time=2022-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233320, encodeId=e0a012333201f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=164c1456793, createdName=zhlgzb, createdTime=Mon Jul 18 23:54:31 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229723, encodeId=8d351229e2327, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Jun 30 14:20:44 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221330, encodeId=a7be122133058, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Sat May 21 07:26:45 CST 2022, time=2022-05-21, status=1, ipAttribution=)]
    2022-05-21 ms3000000376140643

    学习学习

    0